Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 155

    1.

    The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study.

    Herrington DM.

    Ann Intern Med. 1999 Sep 21;131(6):463-6.PMID: 10498564 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

    Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E.

    JAMA. 1998 Aug 19;280(7):605-13.PMID: 9718051 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

    Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group.

    JAMA. 2002 Jul 3;288(1):49-57. Erratum in: JAMA 2002 Sep 4;288(9):1064. PMID: 12090862 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

    Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D; HERS Research Group.

    JAMA. 2002 Jul 3;288(1):58-66.PMID: 12090863 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?

    Wells G, Herrington DM.

    Drugs Aging. 1999 Dec;15(6):419-22. Review.PMID: 10641952 [PubMed - indexed for MEDLINE]Related articles

    6.

    Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators.

    JAMA. 2002 Jul 17;288(3):321-33.PMID: 12117397 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.

    Simon JA, Hunninghake DB, Agarwal SK, Lin F, Cauley JA, Ireland CC, Pickar JH.

    Ann Intern Med. 2001 Oct 2;135(7):493-501.PMID: 11578152 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

    Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB.

    JAMA. 2000 Apr 12;283(14):1845-52.PMID: 10770146 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.

    Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ.

    Ann Intern Med. 2000 Dec 19;133(12):933-41.PMID: 11119394 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)

    Herrington DM, Fong J, Sempos CT, Black DM, Schrott HG, Rautaharju P, Bachorik PS, Blumenthal R, Khan S, Wenger NK.

    Am Heart J. 1998 Jul;136(1):115-24. Erratum in: Am Heart J 1999 Oct;138(4 Pt 1):800. PMID: 9665228 [PubMed - indexed for MEDLINE]Related articles

    12.

    Postmenopausal hormone therapy: cardiovascular risks.

    [No authors listed]

    Prescrire Int. 2003 Apr;12(64):65-9.PMID: 12674130 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS).

    Cauley JA, Black DM, Barrett-Connor E, Harris F, Shields K, Applegate W, Cummings SR.

    Am J Med. 2001 Apr 15;110(6):442-50.PMID: 11331055 [PubMed - indexed for MEDLINE]Related articles

    14.

    Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).

    Herrington DM, Vittinghoff E, Lin F, Fong J, Harris F, Hunninghake D, Bittner V, Schrott HG, Blumenthal RS, Levy R; HERS Study Group.

    Circulation. 2002 Jun 25;105(25):2962-7.PMID: 12081988 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Estrogen plus progestin and the risk of coronary heart disease.

    Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M; Women's Health Initiative Investigators.

    N Engl J Med. 2003 Aug 7;349(6):523-34.PMID: 12904517 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.

    Lemay A.

    J Obstet Gynaecol Can. 2002 Sep;24(9):711-5.PMID: 12360366 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hormone replacement therapy for prevention of coronary heart disease: current evidence.

    Khurana PS, Khurana C, Hsia J.

    Curr Atheroscler Rep. 2001 Sep;3(5):399-403. Review.PMID: 11487451 [PubMed - indexed for MEDLINE]Related articles

    18.

    Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.

    Contreras I, Parra D.

    Am J Health Syst Pharm. 2000 Nov 1;57(21):1963-8; quiz 1969-71. Review.PMID: 11094650 [PubMed - indexed for MEDLINE]Related articles

    19.

    Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

    Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators.

    JAMA. 2003 May 28;289(20):2651-62.PMID: 12771112 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).

    Simon JA, Lin F, Vittinghoff E, Bittner V; for the Heart and Estrogen-Progestin Replacement Study (HERS) Research Group.

    Ann Epidemiol. 2006 Feb;16(2):138-45. Epub 2005 Jul 21.PMID: 16039873 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data